Skip to main content

Table 1 Baseline characteristics of CKD patients with hypertension and diabetes

From: The protective effects of insulin on the developing of dementia in chronic kidney disease patients with hypertension and diabetes: a population-based nationwide study

 

Total

(n = 11,758)

Insulin nonusers

(n = 5,864)

Insulin users

(n = 5,894)

p

Sex

   

< 0.001

 Male (%)

6236 (53)

3205 (54.7)

3031 (51.4)

 

 Female (%)

5522 (47)

2659 (45.3)

2863 (48.6)

 

Age

62.1 \(\:\pm\:\) 10.9

62.6 \(\:\pm\:\) 10.9

61.7 \(\:\pm\:\) 11

< 0.001

 20–39 (%)

860 (7.3)

398 (6.8)

462 (7.8)

0.001

 40–64 (%)

5794 (49.3)

2829 (48.2)

2965 (50.3)

 65–80 (%)

5104 (43.4)

2637 (45)

2467 (41.9)

Comorbidities

    

 Ischemic Heart Disease (%)

2794 (23.8)

1352 (23.1)

1442 (24.5)

0.072

 Hyperlipidemia (%)

6186 (52.6)

3075 (52.4)

3111 (52.8)

0.708

 Atrial Fibrillation (%)

163 (1.4)

92 (1.6)

71 (1.2)

0.091

 CHF (%)

839 (7.1)

357 (6.1)

482 (8.2)

< 0.001

 PAD (%)

439 (3.7)

192 (3.3)

247 (4.2)

0.008

 Asthma (%)

624 (5.3)

298 (5.1)

326 (5.5)

0.277

 COPD (%)

1631 (13.9)

784 (13.4)

847 (14.4)

0.116

 Major Depressive Disorder (%)

129 (1.1)

70 (1.2)

59 (1)

0.315

 Parkinson’s Disease (%)

94 (0.8)

42 (0.7)

52 (0.9)

0.312

 Rheumatoid Arthritis (%)

114 (1)

50 (0.9)

64 (1.1)

0.197

 Insomnia (%)

1012 (8.6)

500 (8.5)

512 (8.7)

0.756

 Hyperthyroidism (%)

102 (0.9)

53 (0.9)

49 (0.8)

0.671

 Hypothyroidism (%)

91 (0.8)

54 (0.9)

37 (0.6)

0.069

 Gout (%)

2019 (17.2)

1164 (1.9)

855 (14.5)

< 0.001

Drugs

    

 BZDs (%)

2473 (21)

1233 (21)

1240 (21)

0.987

 Anticoagulants (%)

5060 (43)

2465 (42)

2595 (44)

0.029

 NSAIDs (%)

4506 (38.3)

2220 (37.9)

2286 (38.8)

0.301

 Acetaminophen (%)

4189 (35.6)

1997 (34.1)

2192 (37.2)

< 0.001

 Statin (%)

4655 (39.6)

2100 (35.8)

2555 (43.4)

< 0.001

 CCB (%)

6483 (55.1)

3143 (53.6)

3340 (56.7)

< 0.001

 ACEIs (%)

3463 (29.5)

1662 (28.3)

1801 (30.6)

0.008

 ARBs (%)

5340 (45.4)

2465 (42.0)

2875 (48.8)

< 0.001

 Metformin (%)

7166 (61)

3411 (58.2)

3755 (63.7)

< 0.001

 Beta-Blocker (%)

4106 (34.9)

1997 (34.1)

2109 (35.8)

0.049

 Diuretics (%)

4269 (36.3)

1873 (31.9)

2396 (40.7)

< 0.001

  1. Abbreviation: CHF, chronic heart failure; PAD, peripheral artery disease, COPD, chronic obstructive pulmonary disease, NSAID, non-steroid anti-inflammatory drug; BZD, benzodiazepine; CCB, calcium channel blocker ACEIs, angiotensin converting enzyme inhibitors; ARBs, angiotensin receptor blockers